CDKN2A and neoplasm: The simultaneous engagement of tumor-promoting and tumor-suppressive pathways is reminiscent of oncogene-induced senescence, a potent tumor suppressive program involving p53 and p16INK4a that can be triggered by aberrant RAS signaling47–50.